Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rossana N Lazcano Segura

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Advances in Anatomic Pathology|July 28, 2025
BAP1 Tumor Predisposition SyndromeRossana N Lazcano Segura, Mai P Hoang
American Journal of Clinical Pathology|September 19, 2025
Role of nucleophosmin 1 immunostain in detecting leukemia cutis of acute myeloid leukemia with NPM1 mutationRossana N Lazcano Segura, Valentina Nardi, Mai P Hoang
Molecular Cancer Therapeutics|January 10, 2026
Identification of CADM1 as an Immunotherapeutic Target and Evaluation of a Novel CADM1-Targeting Antibody-Drug Conjugate in Preclinical Osteosarcoma ModelsYifei Wang, Zhongting Zhang, Caterina Longo, et al.
Cell Genomics|April 18, 2025
Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targetsIga Kołodziejczak-Guglas, Renan L S Simões, Emerson de Souza Santos, et al.
Nature Medicine|November 14, 2025
Microbial signals in primary and metastatic brain tumorsGolnaz Morad, Ashish V Damania, Brenda Melendez, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Advances in Anatomic Pathology|July 28, 2025
BAP1 Tumor Predisposition SyndromeRossana N Lazcano Segura, Mai P Hoang
American Journal of Clinical Pathology|September 19, 2025
Role of nucleophosmin 1 immunostain in detecting leukemia cutis of acute myeloid leukemia with NPM1 mutationRossana N Lazcano Segura, Valentina Nardi, Mai P Hoang
Molecular Cancer Therapeutics|January 10, 2026
Identification of CADM1 as an Immunotherapeutic Target and Evaluation of a Novel CADM1-Targeting Antibody-Drug Conjugate in Preclinical Osteosarcoma ModelsYifei Wang, Zhongting Zhang, Caterina Longo, et al.
Cell Genomics|April 18, 2025
Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targetsIga Kołodziejczak-Guglas, Renan L S Simões, Emerson de Souza Santos, et al.
Nature Medicine|November 14, 2025
Microbial signals in primary and metastatic brain tumorsGolnaz Morad, Ashish V Damania, Brenda Melendez, et al.
Pageof 1